On Donanemab, Plaques Plummet. Off Donanemab, They Stay Away
If clearance of amyloid would be “reasonably likely” to bestow a cognitive benefit – setting the bar rather blow there other antibodies
If clearance of amyloid would be “reasonably likely” to bestow a cognitive benefit – setting the bar rather blow there other antibodies
In the first of our blood flow blogs, Beth Eyre discusses her own research and gives a whistle stop tour about the importance of blood flow.
Blood enters the right atrium, flows through the tricuspid valve into the right ventricle & the heart beats. Dr Yvonne Couch discusses blood flow & dementia
A hurdle in developing Alzheimer’s theraputics that work for people of all ethnicities is recruitment & retention of underrepresented groups in clinical trials
New research reports associations between COVID-19, and persistent cognitive deficits, including the acceleration of Alzheimer’s disease pathology and symptoms.
Transgender adults in the U.S. are more likely to report worsening memory & depression compared to cisgender adults. According to 2 studies reported at the AAIC
Catch-up with Felicity Slocombe, as she discusses what she discovered at her first face-to-face dementia conference & experiences of presenting her work
Positive trends in global education will decrease dementia prevalence but trends in smoking, BMI & high blood sugar counteract the decrease.
Improving air quality may improve cognitive function and reduce dementia risk, according to several studies reported this weeks AAIC.
You may think Aducanumab is the miracle dementia drug we’ve been waiting for, so why do many researchers disagree? Dr Sam Moxon explores
Dr Christina Toomey has worked at the Queen Square Brain Bank for 10 years, in this post we hear about her work and how it helps researchers worldwide
Extracellular Vesicles. Where do they come from, what do they do? Why are they interesting to Dementia Researchers? Dr Yvonne Couch explains.